← Eichor
Condition: Polycystic Kidney Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Polycystic Kidney Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Phase 2 · 43 location(s) · Vertex Pharmaceuticals Incorporated · NCT07161037Analysis of Patients With Autosomal Dominant Polycystic Kidney
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06759142Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · 49 location(s) · The University of Queensland · NCT04939935Amnioinfusion for Fetal Renal Failure
NA · 1 location(s) · Fetal Care Center, PLLC · NCT06728228Well-Formulated Ketogenic Diet Polycystic Kidney Disease
NA · 1 location(s) · Ohio State University · NCT06325644Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Phase 1 · 15 location(s) · AstraZeneca · NCT07228364A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With
Phase 3 · 23 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT04782258Early PKD Observational Cohort Study
Phase N/A · 3 location(s) · University of Kansas Medical Center · NCT02936791Genetics in the Progression of Nephropathies
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06416761Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
Phase 2 · 4 location(s) · University Hospital, Rouen · NCT06291116ADPKD Patient Registry
Phase N/A · 1 location(s) · PKD Foundation · NCT04039061PKD Clinical and Translational Core Study
Phase N/A · 1 location(s) · University of Maryland, Baltimore · NCT01873235Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase N/A · 1 location(s) · Mayo Clinic · NCT04344769Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
Phase N/A · 1 location(s) · King's College London · NCT07260071Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital
Phase N/A · 1 location(s) · Sohag University · NCT06601829Effects of Exogenous Ketosis on Proteinuria and Renal Function
NA · 1 location(s) · Gødstrup Hospital · NCT06867471Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 2 · 1 location(s) · Jemincare · NCT06800651ARPKD Database Study
Phase N/A · 6 location(s) · Children's Hospital of Philadelphia · NCT01401998HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Phase 3 · 12 location(s) · University Medical Center Groningen · NCT05373264Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NA · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT05996731Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
Phase N/A · 4 location(s) · Children's Hospital of Philadelphia · NCT04338048Kidney Sodium Functional Imaging
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05014178Somatosensory Phenotyping of ADPKD
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06970028Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
NA · 1 location(s) · Richard Fatica · NCT07454174RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYC
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07535385NOX4 and Related Biomarkers in ADPKD
Phase N/A · 1 location(s) · Mayo Clinic · NCT04630613National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852The German ADPKD Tolvaptan Treatment Registry
Phase N/A · 12 location(s) · University of Cologne · NCT02497521Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Phase 2 · 2 location(s) · Cantonal Hospital Graubuenden · NCT06435858
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.